{"slug":"hlb","name":"HLB","name_en":"HLB","ticker":"028300.KQ","updated_at":"2026-07-11T10:22:00.234+00:00","canonical":"https://valuechain.wiki/hlb","kicker":"코스닥 대형주","kicker_en":"KOSDAQ large cap","lead":"표적항암제 리보세라닙 개발을 추진하는 바이오 신약 기업이다. 코스닥 시가총액 상위 종목. 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"A biotech advancing development of the targeted anticancer drug rivoceranib. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"신약 개발(리보세라닙)"},{"name":"의료기기·기타"}]},"segments_en":{"parts":[{"name":"Drug development (rivoceranib)"},{"name":"Medical devices and other"}]},"returns_yearly":{"2021":-29.6,"2022":3.3,"2023":134.2,"2024":18.6,"2025":-31,"2026":-34.1},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}